Trump's spy pick 'shocked' by India launching 104 satellites

Washington, Mar 1: US President Donald Trump's top spymaster nominee has said he was "shocked" to read that India successfully launched more than 100 satellites in one go last month.

"I was shocked the other day to read that India, on one rocket launch, deposited more than 100 satellites in space," former Senator Dan Coats told lawmakers yesterday during his confirmation hearing for the position of Director of National Intelligence.

He said the US cannot afford to be seen lagging behind.

"They may be small in size with different functions and so forth but one rocket can send up, I think it was 104 platforms," said Coats, who if confirmed would be in-charge of all major American intelligence agencies including the CIA.

Indian Space Research Organisation (ISRO) on February 15 successfully launched a record 104 satellites on a single rocket from the Sriharikota spaceport in Andhra Pradesh.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments